Fujitsu today announced the development of a secure and efficient AI agent platform to accelerate operational efficiency and ensure stable medical service provision in Japan’s healthcare sector. The new platform includes an orchestrator AI agent, a centralized system that supports the collaboration and coordination of multiple specialized healthcare-specific agents developed by Fujitsu and other partner companies. The initiative aims to contribute to the rapid implementation of world-leading medical operational practices, thereby driving business transformation and improving sustainability within Japan’s healthcare industry. The development of this platform was supported by NVIDIA, a global leader in accelerated computing and foundational AI agent technology.
In 2025, Fujitsu will accelerate commercialization of the platform by collaborating with advanced medical institutions and partners around the world to verify the effectiveness of the newly developed healthcare orchestrator AI agent and develop specific industry-focused AI agents.
Moving forward, under its Fujitsu Uvance business model, which aims to address societal challenges, Fujitsu will continue to transform healthcare and drug discovery through data and AI, realizing a society where personalized treatment opportunities are available to everyone and advancing the well-being of individuals.